-- U.K. Stocks Advance Most in Five Weeks
-- B y   S o f i a   H o r t a   e   C o s t a
-- 2013-05-28T15:48:36Z
-- http://www.bloomberg.com/news/2013-05-28/u-k-stocks-advance-most-in-five-weeks.html
U.K. stocks  advanced the most in five
weeks, with the  FTSE 100 (UKX)  Index heading for its longest monthly
rally since inception, as data showed U.S.  consumer confidence 
and house prices increased.  AstraZeneca Plc (AZN)  rose to a 6 1/2-year high after the
drugmaker said it agreed to buy Omthera Pharmaceuticals Inc. for
about $323 million. GlaxoSmithKline Plc climbed 1.9 percent as
Deutsche Bank AG advised investors to buy the shares.  Persimmon
Plc (PSN)  and  Taylor Wimpey Plc (TW/)  each added at least 3 percent after a
report showed U.K. house prices increased in May.  The FTSE 100 gained 107.67 points, or 1.6 percent, to
6,762.01 at the close in London, its biggest jump since April
23. The benchmark is heading for a 5.2 percent advance in May,
its 12th month of gains, as central banks maintained stimulus
efforts. The broader FTSE All-Share Index also climbed 1.6
percent today, while Ireland’s ISEQ Index added 0.8 percent.  “Investor sentiment has shifted quite a lot from when it
was quite bearish in mid-April,” Michael Kapler, an equities
portfolio manager at Mittelbrandenburgische Sparkasse in
Potsdam,  Germany , said by phone. “U.S. data still drives
markets, but now the rally has been driven by the support
provided by central-bank liquidity, and this isn’t going away
any time soon.”  American Consumers  In the U.S., a report showed that  consumer confidence  in
the world’s largest economy rose this month to the highest level
since February 2008. The Conference Board’s index rose to 76.2,
exceeding the highest estimate in a Bloomberg survey of
economists, from a revised 69 in April.  Separate figures showed the S&P/Case-Shiller index of
property values increased 10.9 percent in March from the same
month last year, the biggest 12-month gain since April 2006,
after advancing 9.4 percent in February. The median projection
of 30 economists surveyed by Bloomberg called for a 10.2 percent
advance.  AstraZeneca, which makes the Crestor cholesterol-lowering
pill, gained 2.7 percent to 3,521.5 pence, its highest price
since October 2006. The company will pay $12.70 a share for
Omthera, a U.S. developer of treatments for abnormal levels of
fats in the bloodstream.  GlaxoSmithKline (GSK)  rose 1.9 percent to 1,782 pence, its
highest price since December 2001. Deutsche Bank raised its
rating on the stock to buy from hold, saying upcoming regulatory
decisions on the company’s drugs may be favorable. The shares
have rallied 33 percent so far this year.  Persimmon advanced 4.9 percent to 1,280 pence, the highest
price in almost six years. Taylor Wimpey and  Berkeley Group
Holdings Plc (BKG)  added 3.2 percent to 100.8 pence and 2.8 percent to
2,182 pence, respectively. U.K.  home prices  rose 0.4 percent in
May, following a 0.3 percent increase in April, a report showed
yesterday.  Victrex Plc (VCT) , a maker of heat-resistant plastics, jumped 8.4
percent to 1,765 pence, for its biggest increase in three years.
The company boosted its  interim dividend  by 15 percent to 10.35
pence a share from 9 pence a share in the year-earlier period.  The number of shares changing hands in FTSE 100-listed
companies was 12 percent lower than the average of the past 30
days, data compiled by Bloomberg shows.  To contact the reporter on this story:
Sofia Horta e Costa in  London  at 
 shortaecosta@bloomberg.net   To contact the editor responsible for this story:
Andrew Rummer at 
 arummer@bloomberg.net  